T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection

Nature

Volumn 523, Issue 7562, 2015, Pages 612-616

  McKinney, Eoin F ^a,b   Lee, James C ^a,b   Jayne, David R W ^a   Lyons, Paul A ^a,b   Smith, Kenneth G C ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; PROGRAMMED DEATH 1 RECEPTOR; INTERLEUKIN 7 RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR; TRANSCRIPTOME;

ANTIGEN; CYTOPLASM; GENETIC ENGINEERING; GENETIC MARKER; IMMUNITY; INFECTIOUS DISEASE; MOLECULAR ANALYSIS;

ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL STRESS; HUMAN; INFECTION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; ANCA ASSOCIATED VASCULITIS; ANIMAL; AUTOIMMUNE DISEASE; GENETICS; IMMUNOLOGY; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; METABOLISM; MOUSE; PATHOLOGY; PHENOTYPE; SYSTEMIC LUPUS ERYTHEMATOSUS; VIROLOGY;

HEPATITIS C VIRUS;

ANIMALS; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIGENS, CD2; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; INFECTION; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; PHENOTYPE; PROGRAMMED CELL DEATH 1 RECEPTOR; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, INTERLEUKIN-7; TRANSCRIPTOME;

EID: 84938397867     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature14468     Document Type: Article

References (55)

1. Wherry, E. J. T cell exhaustion. Nature Immunol. 12, 492-499 (2011).
2. McKinney, E. F. et al. A CD81 T cell transcription signature predicts prognosis in autoimmune disease. Nature Med. 16, 586-591 (2010).
3. Lee, J. C. et al. Gene expression profiling of CD81 T cells predicts prognosis in patients with Crohn disease and ulcerative colitis. J. Clin. Invest. 121, 4170-4179 (2011).
4. Baechler, E. C. et al. Interferon-inducible gene expression signature in peripheral blood cells of patientswithsevere lupus. Proc.Natl Acad. Sci.USA 100,2610-2615 (2003).
5. West, E. E. et al. Tight regulation ofmemory CD81 T cells limits their effectiveness during sustained high viral load. Immunity 35, 285-298 (2011).
6. Aubert, R. D. et al. Antigen-specific CD4 T-cell help rescues exhausted CD8 T cells during chronic viral infection.Proc.NatlAcad. Sci.USA108,21182-21187(2011).
7. Urbani, S. et al. Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses. Hepatology. 44, 126-139 (2006).
8. Wherry, E. J. et al. Molecular signature of CD81 T cell exhaustion during chronic viral infection. Immunity 27, 670-684 (2007).
9. Rangachari, M. et al. Bat3 promotes T cell responses and autoimmunity by repressing Tim-3-mediated cell death and exhaustion. Nature Med. 18, 1394-1400 (2012).
10. Francisco, L. M., Sage, P. T. & Sharpe, A. H. The PD-1 pathway in tolerance and autoimmunity. Immunol. Rev. 236, 219-242 (2010).
11. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545-15550 (2005).
12. Blackburn, S.D. et al.Coregulation ofCD81 T cell exhaustion bymultiple inhibitory receptors during chronic viral infection. Nature Immunol. 10, 29-37 (2009).
13. Sevilla, N. et al. Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells. J. Exp. Med. 192, 1249-1260 (2000).
14. Virgin, H. W.,Wherry, E. J. & Ahmed, R. Redefining chronic viral infection. Cell 138, 30-50 (2009).
15. Gubin, M. M. et al. Checkpoint blockade cancer immunotherapy targets tumourspecific mutant antigens. Nature 515, 577-581 (2014).
16. Baitsch, L. et al. Exhaustion of tumor-specific CD81 T cells in metastases from melanoma patients. J. Clin. Invest. 121, 2350-2360 (2011).
17. Lang, K. S. et al. Inverse correlation between IL-7 receptor expression and CD8 T cell exhaustion during persistent antigen stimulation. Eur. J. Immunol. 35, 738-745 (2005).
18. Mueller, S. N. & Ahmed, R. High antigen levels are the cause of T cell exhaustion during chronic viral infection. Proc. Natl Acad. Sci. USA 106, 8623-8628 (2009).
19. Barber, D. L. et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682-687 (2006).
20. Lyons, P. A. et al. Microarray analysis of human leucocyte subsets: the advantages of positive selection and rapid purification. BMC Genom. 8, 64 (2007).
21. Taylor, M. W. et al. Changes in gene expression during pegylated interferon and ribavirin therapy of chronic hepatitis C virus distinguish responders from nonresponders to antiviral therapy. J. Virol. 81, 3391-3401 (2007).
22. Lauer, G.M. et al. Full-breadth analysis of CD81 T-cell responses in acute hepatitis C virus infection and early therapy. J. Virol. 79, 12979-12988 (2005).
23. Vahey, M. T. et al. Expression of genes associated with immunoproteasome processing of major histocompatibility complex peptides is indicative of protection with adjuvanted RTS,S malaria vaccine. J. Infect. Dis. 201, 580-589 (2010).
24. Nakaya, H. I. et al. Systemsbiology of vaccination for seasonal influenza inhumans. Nature Immunol. 12, 786-795 (2010).
25. Querec, T. D. et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nature Immunol. 10, 116-125 (2009).
26. Hoang, L. T. et al. The early whole-blood transcriptional signature of dengue virus and features associated with progression to dengue shock syndrome in Vietnamese children and young adults. J. Virol. 84, 12982-12994 (2010).
27. Shum, A. K. et al. BPIFB1 is a lung-specific autoantigen associated with interstitial lung disease. Sci. Translat. Med. 5, 206ra139 (2013).
28. Herazo-Maya, J. D. et al. Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis. Sci. Translat. Med. 5, 205ra136 (2013).
29. Kodama, K. et al. Tissue-And age-specific changes in gene expression during disease induction and progression in NOD mice. Clin. Immunol. 129, 195-201 (2008).
30. Elo, L. L. et al. Early suppression of immune response pathways characterizes children with prediabetes in genome-wide gene expression profiling. J. Autoimmun. 35, 70-76 (2010).
31. Stone, J. H. et al. A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS). Arthritis Rheum. 44, 912-920 (2001).
32. Tan, E. M. et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25, 1271-1277 (1982).
33. Isenberg, D. A. et al. BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus. Rheumatology 44, 902-906 (2005).
34. Silverberg, M. S. et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can. J. Gastroenterol. 19, 5A-36A (2005).
35. Harvey, R. F. & Bradshaw, M. J. Measuring Crohn's disease activity. Lancet i, 1134-1135 (1980).
36. Walmsley, R. S., Ayres, R. C., Pounder, R. E. & Allan, R. N. A simple clinical colitis activity index. Gut 43, 29-32 (1998).
37. Whitney, A. R. et al. Individuality and variation in gene expression patterns in human blood. Proc. Natl Acad. Sci. USA 100, 1896-1901 (2003).
38. Le Brigand, K. et al. An open-Access long oligonucleotide microarray resource for analysis of the human and mouse transcriptomes. Nucleic Acids Res. 34, e87 (2006).
39. Smyth,G.K. Linearmodels and empirical bayesmethods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3, 3 (2004).
40. Gentleman, R. C. et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5, R80 (2004).
41. Huber, W., von Heydebreck, A., Sultmann, H., Poustka, A. & Vingron, M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18 (Suppl. 1), S96-S104 (2002).
42. Kauffmann, A., Gentleman, R. & Huber, W. arrayQualityMetrics-A bioconductor package for quality assessment of microarray data. Bioinformatics 25, 415-416 (2009).
43. Johnson, W. E., Li, C. & Rabinovic, A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8, 118-127 (2007).
44. Eisen,M.B., Spellman, P. T., Brown, P.O., &Botstein,D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl Acad. Sci. USA 95, 14863-14868 (1998).
45. Renshaw, B. R. et al. Humoral immune responses in CD40 ligand-deficient mice. J. Exp. Med. 180, 1889-1900 (1994).
46. Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformat. 9, 559 (2008).
47. Barabasi, A. L., & Albert, R.Emergence of scaling in randomnetworks. Science 286, 509-512 (1999).
48. Langfelder, P. & Horvath, S. Eigengene networks for studying the relationships between co-expression modules. BMC Syst. Biol. 1, 54 (2007).
49. van der Laan, M. J. & Pollard, K. S. A new algorithm for hybrid hierarchical clustering with visualization and the bootstrap. J. Stat. Plann. Inf. 117, 275-303 (2002).
50. Ingenuity Pathway Analysis (Ingenuity Systems, 2003).
51. Breiman, L. Random forests. Machine Learn. J. 45, 5-32 (2001).
52. Gentleman, R. et al. Bioinformatics and Computational Biology Solutions Using R and Bioconductor (Springer, 2005).
53. Cramp, M. E. et al. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C. Gastroenterology 118, 346-355 (2000).
54. Bienkowska, J. R. et al. Convergent random forest predictor: methodology for predicting drug response from genome-scale data applied to anti-TNF response. Genomics 94, 423-432 (2009).
55. Toonen, E. J. et al. Validation study of existing gene expression signatures for anti-TNF treatment in patients with rheumatoid arthritis. PLoS ONE 7, e33199 (2012).